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D avid Korn sets up some presumptions, assumptions, and paradigms that need to be challenged. The 
debate, concern, and angst surrounding genetic privacy 
forces us to ask, Are patient groups, researchers, and 
priYacy advocates all talking a different language? Are 
we all approaching privacy from different perspectives? 
How can we get to a point where we can really listen to 
what oth~rs are saying? 
My husband always tells me that I worry too much 
about the privacy of genetic infonnation and the uses to 
which it is put, and that most people walking down the 
street do not think about the issues at all. I got a reality 
check when my mother said, "I read in the newspaper 
about a cancer gene-the so-called Jewish cancer gene 
for colon cancer. A few months ago, I read about an-
other gene for breast and ovarian cancer. Why," she 
asked, "are all those studies looking only at the Jews?" 
I explained to her that genetic researchers were 
studying many different gene pools and ethnic groups, 
such as the Finnish and the Amish. I also told her that 
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researchers are particularly interested in populations 
characterized by "founder's effect. "1 
She said, "I really don't understand any of that. I 
see in this newspaper article that the researchers used 
some samples from people who had undergone testing 
for Tay-Sachs syndrome. Didn't you get a Tay-Sachs test 
before you were pregnant with Andrea?" When I said 
yes, she asked, "Did they use your sample?" 
I said, "I have no idea. The samples are anony-
mized." She asked, "How could they use anonymized 
samples?" 
I thought this was a good reality check. Most of us 
have been in the hospital. or we have had a relative in 
the hospital. The first time I heard that my tissue sample 
was being used for research, when I had not given it to 
anybody for that purpose, I questioned the propriety of 
that. Would I have agreed to submit a tissue sample if I 
had known that it was going to be used in research~ Prob-
ably, although I am more cautious now than I was a few 
years ago. In fact, the little empirical data we have indi-
cates that most of us, if asked. would consent to allow 
our tissue samples to be used in research. 
The key question for us is, vVhat if we are not asked? 
What implications does that have for a public backlash 
against science? How much of the public's trust and sup-
port for science is going to be further eroded if consent 
procedures are not clear? Patients should know that when 
l. The genetic composition of any particular population is 
known as its gene pool. When a few indi>iduals leave a large popula-
tion and start their own new isolated population, a gene that is rela-
tively rare in the large gene pool can become common in the new 
gene pool. Founder's effect occurs when a particular gene becomes 
disproportionately represented in a population because many of its 
members can trace their lineage back to a few indi.,.iduals. 
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they have a blood or tissue sample taken in the course of 
a clinical visit, a portion of it is stored for their benefit . 
. After all, tissue samples are stored primarily for the 
patient's protection, for accreditation, and for liability 
reasons. 
Research is a public benefit that Dr. Kom, and in-
deed many of us, want to support. But how do we com-
municate that value -vvithout creating a public backlash? 
The first question we have to examine then becomes, 
'Why do we even care about genetic privacy? Some of us 
are afraid that the information \\ill be misused. That 
concern causes us to commingle concerns about genetic 
discrimination and genetic privacy. It is hard, as a public 
policy matter, to separate genetic discrimination and 
privacy because an individual who believes that he has 
been discriminated against has the difficult task of prov-
ing it; a person may not even know that his information 
was actually used. Therefore, it becomes important to 
protect access to the information, not just to erect safe-
guards against discrimination. We create a false di-
chotomy when we separate privacy issues from 
discrimination protections; the two have to be taken to-
gether as a package. 
A second reason that we care about genetic privacy 
is that it encourages research. If we cannot assure pa-
tients that their genetic information will be kept private 
or at least that physicians will do the best they can to 
keep it confidential, patients will not want to be research 
subjects, at least in situations in which we require in-
formed consent. If that indeed is the rationale for why 
we care about genetic privacy, then why have Dr. Kom 
and many other scholars set up a paradigm that balances 
concern for privacy with public benefit and research? I 
do not like that paradigm. It does not encourage broad-
based community support for biomedical research. In-
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stead, I would like to see a paradigm that actively builds 
up public trust so that patients can support our research 
agenda. We should make the public a parmer in bio-
medical research, rather than create a dichotomy be-
tween private rights and public benefit and then try to 
maintain a precarious balance. 
There are three Cs to think about when discussing 
genetic privacy. The first is context. The most important 
reason we care about genetic privacy is that it is a social 
value. Independent of caring about misuse and indepen-
dent of caring about our agenda for research, it is just 
something we, as a community, want to encourage and 
promote. Genetic privacy is a value that is the basis of 
being an individual. It is a value that we care about in 
the context of our family, and it is a value that we care 
about for our community. Therefore. context matters. 
It matters whether samples are collected in a clinical 
context or in a research context. There is a lot of gray-
ing around the edges, particularly with genetic testing, 
but we need to ask, first, what the expectation of the 
individual is at the time his tissue sample is collected-
whether in the clinical context or the research context. 
How do we recognize what the patient's expectation is 
and deal \vith the patient's knowledge needs? 
The second Cis control. If we want patients to sup-
port the research establishment, we have to give patients 
some sense of control. That is what my mother's phone 
call was about: Who gave the researchers permission to 
use the Tay-Sachs test results? Did the subjects consent 
to the use of their tissue samples? 
The third Cis a sense of community. Supporting • 
research in a partnership is a communitarian effort, 
but that does not mean only recognizing the benefits 
to the community. It also requires recognizing that 
there are risks to a community. That was my mother's 
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final point, when she asked why they were picking on 
us. Nobody is "picking on us." We need to put the "pick-
ing on us" in context with the science and the needs of 
our community. 
We should think about the themes of context, con-
trol, and community when we reexamine the paradigm 
that requires us to balance concern for private rights 
. with public benefit and research. 
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